[go: up one dir, main page]

ES2110256T3 - Derivados heteroaromaticos triciclicos fundidos como ligandos de subtipos de receptores de dopamina. - Google Patents

Derivados heteroaromaticos triciclicos fundidos como ligandos de subtipos de receptores de dopamina.

Info

Publication number
ES2110256T3
ES2110256T3 ES94925560T ES94925560T ES2110256T3 ES 2110256 T3 ES2110256 T3 ES 2110256T3 ES 94925560 T ES94925560 T ES 94925560T ES 94925560 T ES94925560 T ES 94925560T ES 2110256 T3 ES2110256 T3 ES 2110256T3
Authority
ES
Spain
Prior art keywords
ligands
dopamine receptor
receptor subtypes
heteroaromatic derivatives
derivatives fused
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94925560T
Other languages
English (en)
Inventor
Ian James Collins
Paul David Leeson
Michael Rowley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organon Pharma UK Ltd
Original Assignee
Merck Sharp and Dohme Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp and Dohme Ltd filed Critical Merck Sharp and Dohme Ltd
Application granted granted Critical
Publication of ES2110256T3 publication Critical patent/ES2110256T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)

Abstract

UNA CLASE DE COMPUESTOS HETEROAROMATICOS TRICICLICOS UNIDOS DE FORMULA (I), O UNA SAL DE LOS MISMOS O UN PROFARMACO DE LOS MISMOS QUE CONTIENE UN ANILLO DE PIRAZOL UNIDO SON LIGANDOS DE SUBTIPOS RECEPTORES DE DOPAMINA EN EL CUERPO Y SON POR ELLO UTILES EN EL TRATAMIENTO Y/O PREVENCION DE ENFERMEDADES DEL SISTEMA DE DOPAMINA, COMO ESQUIZOFRENIA.
ES94925560T 1993-09-09 1994-09-06 Derivados heteroaromaticos triciclicos fundidos como ligandos de subtipos de receptores de dopamina. Expired - Lifetime ES2110256T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939318691A GB9318691D0 (en) 1993-09-09 1993-09-09 Therapeutic agents

Publications (1)

Publication Number Publication Date
ES2110256T3 true ES2110256T3 (es) 1998-02-01

Family

ID=10741750

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94925560T Expired - Lifetime ES2110256T3 (es) 1993-09-09 1994-09-06 Derivados heteroaromaticos triciclicos fundidos como ligandos de subtipos de receptores de dopamina.

Country Status (10)

Country Link
US (1) US5686480A (es)
EP (1) EP0717733B1 (es)
JP (1) JPH09502199A (es)
AT (1) ATE160773T1 (es)
AU (1) AU684304B2 (es)
CA (1) CA2168738A1 (es)
DE (1) DE69407191T2 (es)
ES (1) ES2110256T3 (es)
GB (1) GB9318691D0 (es)
WO (1) WO1995007262A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19519056A1 (de) * 1995-05-24 1997-01-16 Klinge Co Chem Pharm Fab Verwendung von Antidepressiva zur Behandlung von Asthma und/oder Atemwegserkrankungen mittels inhalatorischer Applikation
US6187774B1 (en) * 1996-03-04 2001-02-13 Yoshitomi Pharmaceutical Industries, Ltd. Fused heterocyclic compounds and pharmaceutical applications thereof
AU6242999A (en) * 1998-09-02 2000-03-21 Neurogen Corporation 2-aryl-4-(1-(4-heteroaryl)piperazin-1-yl) methylimidazoles: dopamine d4 receptor subtype ligands
US6107313A (en) * 1998-10-02 2000-08-22 Combichem, Inc. Dopamine receptor antagonists
US6462036B1 (en) * 1998-11-06 2002-10-08 Basf Aktiengesellschaft Tricyclic pyrazole derivatives
AU2002341729A1 (en) * 2001-09-19 2003-04-01 Pharmacia Corporation Substituted pyrazolyl compounds for the treatment of inflammation
TW200409777A (en) * 2002-08-12 2004-06-16 Janssen Pharmaceutica Nv C-substituted tricyclic isoxazoline derivatives and their use as anti-depressants
DE60319388T2 (de) 2002-08-21 2009-02-19 Janssen Pharmaceutica N.V. C6- und C9-substituierte Chromeno[4,3-c]Isoxazoline und ihre Verwendung als Anti-Depressiva
ATE537151T1 (de) 2006-10-31 2011-12-15 Pfizer Prod Inc Pyrazolinverbindungen als mineralocorticoidrezeptorantagonisten
CA2685888A1 (en) * 2007-05-09 2008-11-20 Pfizer Inc. Substituted heterocyclic derivatives and their pharmaceutical use and compositions
JP2012506848A (ja) * 2008-10-27 2012-03-22 グラクソ グループ リミテッド グルタミン酸受容体モジュレーターとしての三環式化合物
DE102010055499A1 (de) * 2010-12-22 2011-06-16 W.C. Heraeus Gmbh Prozess zur Herstellung von Bendamustinalkylester, Bendarmustin sowie Derivaten davon

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3553230A (en) * 1967-09-26 1971-01-05 Colgate Palmolive Co 3-aminoalkyl and 3-amino derivatives of 4h(1)benzopyrano(3,4-d)isoxazoles
US3969527A (en) * 1975-07-28 1976-07-13 E. R. Squibb & Sons, Inc. CNS active compounds
ATE126512T1 (de) * 1989-05-19 1995-09-15 Hoechst Roussel Pharma N-(aryloxyalkyl)heteroarylpiperidine und - heteroarylpiperazine, verfahren zu ihrer herstellung und ihre verwendung als medikamente.
CA2146018A1 (en) * 1992-10-23 1994-05-11 Paul David Leeson Dopamine receptor subtype ligands

Also Published As

Publication number Publication date
EP0717733B1 (en) 1997-12-03
WO1995007262A1 (en) 1995-03-16
CA2168738A1 (en) 1995-03-16
DE69407191D1 (de) 1998-01-15
AU7542594A (en) 1995-03-27
US5686480A (en) 1997-11-11
EP0717733A1 (en) 1996-06-26
GB9318691D0 (en) 1993-10-27
JPH09502199A (ja) 1997-03-04
ATE160773T1 (de) 1997-12-15
AU684304B2 (en) 1997-12-11
DE69407191T2 (de) 1998-07-02

Similar Documents

Publication Publication Date Title
ES2110256T3 (es) Derivados heteroaromaticos triciclicos fundidos como ligandos de subtipos de receptores de dopamina.
ES2127946T3 (es) Antagonistas de neurocinina diazabiciclica.
ES2102488T3 (es) Naftopiranos fotocromicos.
MX9304819A (es) Nuevos derivados de xantina y procedimiento para su preparacion.
ES2132105T3 (es) 2-aminometil-cromanos como principios activos en farmacos para el tratamiento de enfermedades del sistema nervioso central.
MX9500224A (es) Procedimiento para la obtencion de poliolefina.
ATE160774T1 (de) Antipsychotische benzimidazolderivate
ES2145911T3 (es) Compuestos de naftopirano fotocromicos.
ES2147739T3 (es) Fosfonooximetil-eteres de derivados de taxano.
ES2071334T3 (es) Analogos de anillos fusionados de nitrogeno conteniendo heterociclos no aromaticos.
AR048567A1 (es) Derivados de benzoxazinona, su preparacion y composiciones farmaceuticas.
UY38809A (es) Derivados de 3,6-diamino-piridazin-3ilo, composiciones farmacéuticas que los contienen y sus usos como agentes proapoptóticos
UY30397A1 (es) Derivados sustituidos de la (3as, 7as)-1,3a,4,5,6,7-hexahidro-3h-benzoimidazol-2-ona, proceso de preparacion, composiciones conteniéndolos yaplicaciones
CL2020001817A1 (es) Moduladores del receptor c5a
ES2132882T3 (es) Compuestos de 1-aril-2-acilamino-etano y su uso como antagonistas de neuroquinina 1.
ES2092981T3 (es) Derivados de aristeromicina/adenosina.
MX9306679A (es) Penems 6-(metilen-sustituidos), derivados de los mismos, proceso para su preparacion y composicion farmaceutica que los contiene.
CO4810376A1 (es) Derivados de eritromicina triciclicos
BR0314796A (pt) Piperazinas substituìdas heterocìclicas para o tratamento de esquizofrenia
ES2139595T3 (es) Derivados triazolicos triciclicos, fabricacion de los mismos y su utilizacion.
ES2108149T3 (es) Derivado de cefalosporina.
AR012990A1 (es) Compuestos de benzo(5,6) cicloheptapiridina, composiciones farmaceuticas que los contienen, y el uso de dichos compuestos como inhibidores de laproteina farnesil transferasa.
ES2075976T3 (es) Derivados de aminoacido y su empleo como agentes antiviricos.
BR0115119A (pt) Derivados tricìclicos de indol com atividade antiangiogênica
ES2149193T3 (es) Compuestos heterociclicos sustituidos con alquilo.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 717733

Country of ref document: ES